USPTO serial 79290049
Reviewed by CopyMark Law Group
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $975
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Anne Wang
Anne Wang FROST BROWN TODD LLP301 East Fourth Street3300 Great American TowerCincinnati, OH 45202| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Medical apparatus and instruments, namely, medical apparatus and instruments for use in neuromodulation and medical apparatus and instruments for the diagnosis, monitoring, management and treatment of hearing disorders; electronic medical apparatus, namely, electronic medical apparatus for use in neuromodulation and the electronic medical apparatus for the diagnosis, monitoring, management and treatment of hearing disorders; medical diagnostic devices and instruments, namely, medical diagnostic devices and instruments for use in neuromodulation and medical diagnostic devices and instruments for the diagnosis, monitoring, management and treatment of hearing disorders; medical devices and instruments for monitoring and treating health and medical conditions, namely, medical devices and instruments for monitoring and treating health and medical conditions by way of neuromodulation and medical devices and instruments for monitoring and treating health and medical conditions, namely, hearing disorders; medical implants, namely, medical implants for use in neuromodulation and medical implants for the diagnosis, monitoring, management and treatment of hearing disorders, all being made from artificial materials; wearable medical devices, namely, wearable medical devices for use in neuromodulation and wearable medical devices for the diagnosis, monitoring, management and treatment of hearing disorders; hearing aids; apparatus for use in alleviating hearing disorders, namely, hearing aids and cochlea implants made of artificial materials; apparatus for use in treating hearing disorders, namely, hearing aids and cochlear implants made of artificial materials; apparatus for use in the diagnosis, monitoring and treatment of neurological conditions and central nervous system disorders, namely, hearing disorders; sensors being measurement apparatus for medical use, namely, biofeedback sensors | ACTIVE | — |
| 016 | Printed matter, namely, books, journals, magazines and brochures in the field of medical research and medical practice; printed publications, namely, books, journals, magazines and brochures in the field of medical research and medical practice; printed journals in the field of medical research and medical practice; printed newsletters and magazines in the field of medical research and medical practice; all the aforementioned being in relation to medical research and medical matters | ACTIVE | — |
| 042 | Medical research; medical research in the field of neurological conditions and central nervous system disorders; medical research in the field of Parkinson's disease; medical research in the field of epilepsy; medical research in the field of hearing disorders; technological research and design in the field of medical devices, apparatus and instruments; technological research and design of computer hardware, firmware and software for use in the medical field; software as a service (SaaS) featuring software, hosting online non-downloadable software for use in the medical field, namely, for use with medical devices for the diagnosis, monitoring, management and treatment of health and medical conditions; Platforms as a Service (Paas) for use in the medical field, namely, providing online non-downloadable software for use with medical devices for the diagnosis, monitoring, management and treatment of health and medical conditions; providing online non-downloadable computer firmware and computer software for use in the medical field, namely, for use with medical devices for the diagnosis, monitoring, management and treatment of health and medical conditions | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 12, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 12, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Sep 12, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 12, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 12, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 12, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Apr 24, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 5, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 5, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 26, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 26, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 10, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 10, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 8, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 21, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 21, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 21, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 7, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 30, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 29, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 29, 2021 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Apr 12, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 12, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 12, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 16, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 15, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 15, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 8, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 8, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 8, 2021 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Mar 8, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 8, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 8, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Mar 6, 2021 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Oct 4, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 16, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 15, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 21, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 20, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 12, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 28, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 24, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 23, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |